3,674
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Antibacterial activity of some bryophytes used traditionally for the treatment of burn infections

, , , &
Pages 526-530 | Received 23 Feb 2010, Accepted 07 Sep 2010, Published online: 11 Mar 2011

Abstract

Context: Plagiochasma appendiculatum L. & L. (Aytoniaceae), Conocephalum conicum (L.) Necker (Conocephalaceae), Bryum argenteum Hedw. (Bryaceae), and Mnium marginatum (With.) P. Beauv. (Mniaceae) are bryophytes (liverworts and mosses) used by traditional healers for the treatment of burn, cuts, wounds, and skin disorders.

Objective: This study evaluated the antibacterial activity of four bryophytes against some common bacteria responsible for burn infections.

Materials and methods: Different fractions of bryophytes were screened using the disc diffusion (qualitative) and broth microdilution (quantitative) methods, according to the guidelines of the National Committee for Clinical and Laboratory Standards.

Results and discussion: Chloroform fractions of liverworts were more active against Gram negative strains while butanol fractions of mosses had significant activity against Gram positive bacteria. Staphylococcus aureus was the most sensitive strain of those tested with the butanol fraction of M. marginatum (moss), with the strongest inhibition zone of 102.92% and minimum inhibitory concentration of 30 μg mL−1.

Conclusion: Our findings support the use of the bryophytes in traditional medicine for burn infections because of their significant antibacterial activity.

Introduction

Plagiochasma appendiculatum L. & L., Aytoniaceae, Conocephalum conicum (L.) Necker, Conocephalaceae (Liverworts), Bryum argenteum Hedw., Bryaceae, and Mnium marginatum (With.) P. Beauv., Mniaceae (Mosses) are bryophytes used by traditional healers for the treatment of boils, burns, cuts, eczema, skin disorders, and wounds and are also reported as an antimicrobial, antioxidant, antipyretic, and antidotal agent (CitationCrum, 1973; CitationDing, 1982; CitationPant and Tewari, 1989; CitationZehr, 1990; CitationToyota and Asakawa, 1999; CitationKumar et al., 2000). The use of bryophytes in herbal medicines has been common in China, India, and among Native Americans since ancient times. Numerous compounds, including oligosaccharides, polysaccharides, sugar alcohols, amino acids, fatty acids, aliphatic compounds, prenylquinones, and aromatic and phenolic compounds occur in bryophytes, but few links have been made between any medical effects and specific bryophyte species or compounds as compared with vascular plants (CitationFlowers, 1957; CitationHuneck, 1983; CitationAsakawa, 1984; CitationPant and Tewari, 1990).

Burn injury is a major concern in many parts of the world: approximately 75% of all deaths are reported to be due to infections. Burn wounds consisting of moist necrotic tissue represent an ideal culture medium for a wide variety of microorganisms (Altoparlak et al., Citation2004). The most common pathogens causing serious infection in burn patients are Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, Proteus mirabilis, and Clostridium spp. (CitationAl-Akayleh, 1999; Lawrence, Citation1999; Gnanamani et al., Citation2003; Soares De Macedo and Santos, Citation2006).

Bryophytes (liverworts and mosses) are traditionally used in India by different cultural groups for burns, cuts, wounds, and skin diseases, suggesting that they protect the skin and open wounds from microbial pathogens (CitationPant & Tewari, 1990; CitationSaxena & Harinder, 2004; CitationSubhisha & Subramoniam, 2005). Some reports are available for the chemical constituents of these four bryophytes such as sesquiterpenoids and cyclic bis-bibenzyls (CitationToyota & Asakawa, 1999) isolated from P. appendiculatum; sesquiterpene lactones, lunularic acid, and flavonoids (apigenin, luteolin, etc.) (CitationConnolly, 1994) isolated from C. conicum; and apigenin, apigenin-7-O-triglycoside, vitexin and luteolin-7-O-neohesperidoside, and saponarin (Basile et al., Citation1999) isolated from both B. argenteum and M. marginatum.

The main purpose of this study was to identify and obtain information on the bryophytes that are used by traditional healers in the management of burn infections.

Materials and methods

Plant material and extraction

The bryophytes, including liverworts and mosses, were collected during the month of September and October 2006, from different places of Uttaranchal, India. The plants were identified by Dr. Virendra Nath, and voucher specimens were deposited in the Bryophytes Herbarium at the National Botanical Research Institute, Lucknow. The voucher specimen numbers are LWG-226840, 247532, 228212, and 226950 for P. appendiculatum, C. conicum, B. argenteum, and M. marginatum, respectively. Air-dried and powdered materials were successively extracted by cold percolation in polar and non-polar organic solvents. The extracts were decanted, filtered with Whatman No. 1 filter paper, concentrated at reduced pressure below 40°C through a Rotavapor, and lyophilized (Labcanco, Kansas, MO). The extract yields are given in .

Figure 1.  Yield percentage of different fractions of plant extracts.

Figure 1.  Yield percentage of different fractions of plant extracts.

Antimicrobial activity assays

Two different methods were used for the determination of antimicrobial activities: disc diffusion and microdilution assays as recommended by the National Committee for Clinical Laboratory Standards (CLSI/NCCLS, 2006). All tests were performed in triplicate.

Microbial strains

Bacillus cereus (MTCC, 430), Bacillus subtilis (MTCC, 121), Escherichia coli (MTCC, 443), Klebsiella pneumoniae (MTCC, 109), Pseudomonas aeruginosa (MTCC, 424), S. aureus (MTCC, 96), S. pyogenes (MTCC, 1927), Enterococcus faecalis (MTCC, 439), Enterobacter aerogenes (MTCC, 111), and P. mirabilis (MTCC, 1429) were used as test microorganisms. These test organisms were grown on Muller Hinton Broth (MHB; Oxoid, Basingstoke, UK) at 37°C for 6–12 h.

Inocula preparation

Stock bacterial inocula suspensions were obtained from the culture grown on MHB at 37°C for 6–12 h. These final suspensions are used for the inocula preparation. The cell density of each suspension was determined using a counting chamber adjusted to 0.5 McFarland turbidity at the concentration of 105–106 colony forming units mL−1 by dilution with MHB, as per the NCCLS guidelines.

Antimicrobial assay by disc diffusion assay

The dried extracts and oil were dissolved in 2.5% dimethylsulfoxide to a final concentration of 30 mg mL−1 and sterilized by filtration through 0.45-μm Millipore filters. The disc (6 mm in diameter; HiMedia, Mumbai, India) was impregnated with 10 μL of 30 mg mL−1 crude and placed on seeded agar. Erythromycin (30 μg per disc) was used as a positive control, and test plates were incubated at 37°C for 18–24 h depending on incubation time required for visible growth. Antimicrobial activity was evaluated by measuring the zone of inhibition against test organisms with the help of Hi Antibiotic zone scale (HiMedia).

Standard microdilution method (NCCLS)

The test is performed in sterile U bottom 96-well plates by dispensing 95 μL of MHB and 5 μL of inoculum into each well (0.5 McFarland turbidity). Finally, 100 μL of test materials was added to appropriate well. The final volume in each well was 200 μL. A standard antibiotic, erythromycin (Sigma, St. Louis, MO), was used as the positive control. The plates were covered with sterile sealer and incubated at 37°C for 18–24 h. To indicate bacterial growth, 40 μL of 0.2 mg mL−1 p-iodonitrotetrazolium violet (Sigma) solution was added to each well and incubated for further 30 min. Inhibition of bacterial growth was visible as a clear well and the presence of growth was detected by the presence of pink-red color. In this study, we tested concentration of fractions ranging from 10,000 to10 μg mL−1 for mosses, 15,000 to10 μg mL−1 for liverworts, and 1000 to10 μg mL−1 for erythromycin.

Determination of minimum inhibitory and bactericidal concentrations

Inhibition of bacterial growth was visible as clear wells, and the presence of growth was detected by the appearance of pink-red color. The minimum inhibitory concentration (MICs) and the minimum bactericidal concentration (MBCs) of extract and standard drugs were determined by the microdilution method (well showing the minimum turbidity) and streaking a 5-μL sample of the same well onto an over-dried agar (MH) plate and then incubating at 37°C for 18–24 h.

Results and discussion

The antibacterial activity of hexane, chloroform, butanol, and methanol extracts of four bryophytes including two liverworts (P. appendiculatum and C. conicum) and two mosses (B. argenteum and M. marginatum) against common flora of burn infection tested in this study were qualitatively (disc diffusion) and quantitatively (microdilution) assayed ( and ). The results showed that almost all the extracts of these four different bryophyte species have antibacterial activity against most of the tested bacterial strains with the strongest being M. marginatum, followed by P. appendiculatum, B. argenteum, and C. conicum. In the case of the liverworts, the chloroform fraction showed significant activity, whereas in the case of mosses, the butanol fraction was most active. Most of the liverworts reportedly contain sesqui- and diterpenoids in major amount along with lipophilic aromatic compounds, which are mainly constituted in the oil bodies, whereas in mosses a variety of flavonoids have been isolated (CitationAsakawa, 1981, 1990; CitationConnolly, 1994; Basile et al., Citation1999).

Table 1.  Antibacterial activity* of some fractions (conc. 30 mg mL−1) of Indian bryophytes.

Table 2.  MIC and MBC values of liverwort (chloroform) and mosses (butanol) fraction of Indian bryophytes (μg mL−1).

The results indicate that Gram positive S. aureus was the most sensitive strain of those tested with the butanol fraction of M. marginatum (moss), with the strongest inhibition zone of 102.92% (in relation to standard drug erythromycin). The butanol fraction also exhibited significant antimicrobial activity against E. coli (106.84%), S. pyogenes (92%), B. cereus (92.48%), and B. subtilis (94.73 %). P. aeruginosa was found to be more sensitive among the Gram negative bacteria tested with an inhibition zone of 92.52 and 120.32% in chloroform fractions of liverworts (P. appendiculatum and C. conicum). Thus, the significance of the activity of liverwort extracts for medical application lies in its very selective inhibition of specific Gram negative bacteria, without affecting other bacteria, which is very rarely seen in higher plants and needs to be highlighted and further studied. The production of antibacterial substances is a wide-spread phenomenon in bryophytes, as different literature data have shown (CitationAsakawa, 1982a, Citation1982b).

The MIC values were also recorded for the bacterial strains that were found to be most sensitive to the extracts in disc diffusion assay. There are no validation criteria for MIC and end points for in vitro testing of plant extracts. Based on the above observation, all bryophyte extracts showed strong activity except P. appendiculatum (1870 μg mL−1), B. argenteum, and M. marginatum (1250 μg mL−1) against B. subtilis, P. aeruginosa, and E. faecalis.

This study shows that the information obtained from traditional healers can lead to discovery of therapeutically useful antibacterial agents against common bacteria responsible for burn infection. As infection is a major cause of morbidity and mortality in burn patients, these bryophyte extracts may prevent infection that could lead to high risk of sepsis, and thereby prevent the prolongation of the inflammatory phase. Thus, the results of this study suggest a fairly good correlation between traditional therapeutic use and in vitro antibacterial activity.

Conclusions

Bryophytes including liverworts and mosses that are traditionally used in the treatment of burn infections or related ailments could be a good source for new, safe, biodegradable, and renewable antimicrobial agents.

Acknowledgment

The authors are grateful to the Director of the National Botanical Research Institute for his kind support and encouragement.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  • Al-Akayleh AT. (1999). Invasive burn wound infection. Ann Burns Fire Dis, 12, 204–209.
  • Altoparlak U, Erol S, Akcay MN, Celebi F, Kadanali A. (2004). The time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns, 30, 660–664.
  • Asakawa Y. (1981). Biologically active substances obtained from bryophytes. J Hatt Bot Lab, 50, 123–142.
  • Asakawa Y. (1982a). Chemical constituents of the Hepaticae. In: Herz W, Grisebach H, and Kirby GW, eds. Progress in the Chemistry of Organic Natural Products, Vol. 42. Vienna: Springer, 1–285.
  • Asakawa Y. (1982b). Terpenoids and aromatic compounds as chemosystematics indicators. J Hatt Bot Lab, 53, 283–293.
  • Asakawa Y. (1984). Some biologically active substances isolated from Hepaticae: Terpenoids and lipophilic aromatic compounds. J Hatt Bot Lab, 56, 215–219.
  • Asakawa Y. (1990). Terpenoids and aromatic compounds with pharmacological activity from bryophyte. In: Zinsmeister HD, Mues R, eds. Bryophytes: Their Chemistry and Chemical Taxonomy. Oxford: Clarendon Press, 369–410.
  • Basile A, Giordano S, López-Sáez JA, Cobianchi RC. (1999). Antibacterial activity of pure flavonoids isolated from mosses. Phytochemistry, 52, 1479–1482.
  • CLSI/NCCLS. (2006). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 7th edition NCCLS document M7-A7. Wayne, PA: National Committee for Clinical Laboratory Standards.
  • Connolly JD. (1994). Terpenoids from the Hepaticae. J Hatt Bot Lab, 76, 263–272.
  • Crum H. (1973). Mosses of the Great Lakes forest. Contributions from the University of Michigan Herbarium, 10, 404.
  • Soares de Macedo JL, Santos JB. (2006). Nosocomial infections in a Brazilian Burn Unit. Burns, 32, 477–481.
  • Ding H. (1982). Medicinal Spore Bearing Plants of China. Shanghai: Shanghai Science and Technology Press.
  • Flowers S. (1957). Ethnobryology of the Gosuite Indians of Utah. Bryologist, 6, 11–14.
  • Gnanamani A, Priya KS, Radhakrishnan N, Babu M. (2003). Antibacterial activity of two plant extracts on eight burn pathogens. J Ethnopharmacol, 86, 59–61.
  • Huneck S. (1983). Chemistry and biochemistry of bryophytes. In: Schuster RM, ed. New Manual of Bryology, Miyazaki, Japan: Hattori Botanical Laboratory, Nichinan, 1–116.
  • Kumar K, Singh, KK, Asthana AK, Nath V. (2000). Ethnotherapeutics of bryophyte Plagiochasma appendiculatum among the Gaddi tribes of Kangra Valley, H.P. India. Pharm Biol, 38, 353–356.
  • Lawrence JC. (1999). Swab taking. J Wound Care, 8, 251.
  • Pant G, Tewari SD. (1989). Various human uses of bryophytes in the Kumaun region of Northwest Himalaya. Bryologist, 9, 120–122.
  • Pant G, Tewari SD. (1990). Bryophytes and mankind. Ethnobotany, 2, 97–103.
  • Saxena DK, Harinder. (2004). Uses of bryophytes. Resonance, 56–65.
  • Subhisha S, Subramoniam A. (2005). Antifungal activities of a steroid from Pallavicinia lyellii, a liverwort. Ind J Pharmacol, 37, 304–308.
  • Toyota M, Asakawa Y. (1999). Sesquterpenoids and cyclic bis (bibenzyls) from the Pakistani liverwort Plagiochasma appendiculatum. J Hatt Bot Lab, 86, 161–167.
  • Zehr DR. (1990). A simplified technique for assaying the production of bacteriostatic compounds by hepatics. Lindbergia, 16, 128–132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.